NCT00153634: Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF) |
|
|
| Completed | N/A | 75 | US | IV amikacin, PO azithromycin, IV ceftazidime, PO ciprofloxacin, IV meropenem, IV piperacillin-tazobactam, IV ticarcillin-clavulanate, IV tobramycin | Seattle Children's Hospital, Cystic Fibrosis Foundation | Cystic Fibrosis, Chronic Bronchitis | | 11/07 | | |
NCT02800785: The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial |
|
|
| Completed | N/A | 1552 | US | Cefoxitin, Ertapenem, Moxifloxacin, Tigecycline, Ticarcillin-Clavulanic Acid; Metronidazole plus Cefazolin, Cefuroxime, Ceftriaxone, Cefotaxime, Ciprofloxacin, or Levofloxacin, Appendectomy | University of Washington, Patient-Centered Outcomes Research Institute | Appendicitis | 03/20 | 09/21 | | |
